Ulusoy E, Edeer-Karaca N, Özen S, Ertan Y, Gökşen D, Aksu G, Darcan Ş, Kütükçüler N. An unusual manifestation: Papillary thyroid carcinoma in a patient with ataxia-telengiectasia. Turk J Pediatr 2016; 58: 442-445.Ataxia-telangiectasia (A-T) is a rare autosomal recessive, multisystem, neurodegenerative disorder, characterized by oculocutaneous telangiectasias, variable immunodeficiency and progressive neurological impairment. Definitive diagnosis is made by revealing a disease causing mutation on ATM gene. Missense mutations and polymorphisms of ATM gene can play a role in the development of thyroid papillary carcinoma. A 13-year-old Turkish girl was diagnosed with ataxia telengiectasia at the age of 8 years. When she was 12 years old, multi-nodular goiter was detected by physical examination and ultrasonography. She underwent thyroidectomy and histopathologic investigation revealed a papillary carcinoma with follicular variant. The patient received post-operative radioiodine therapy as well as L-thyroxine treatment because she had residual lesions. Up until now, she is the first Turkish child wit A-T and thyroid carcinoma described in the literature.
___
1. Azarsiz E, Karaca NE, Gunaydin NC, et al. Do elevated serum IgM levels have to be included in probable diagnosis criteria of patients with ataxia-telangiectasia? Int J Immunopathol Pharmacol 2014; 27: 421-427.
2. Chaudhary MW, Al-Baradie RS. Ataxia-telangiectasia: future prospects. Appl Clin Genet 2014; 7: 159-167.
3. Brasseur B, Beauloye V, Chantrain C, et al. Papillary thyroid carcinoma in a 9-year-old girl with ataxiatelangiectasia. Pediatr Blood Cancer 2008; 50: 1058- 1060.
4. Sandoval C, Schantz S, Posey D, Swift M. Parotid and thyroid gland cancers in patients with ataxiatelangiectasia. Pediatr Hematol Oncol 2001; 18: 485- 490.
5. Song CM, Kwon TK, Park BL, Ji YB, Tae K. Single nucleotide polymorphisms of ataxia telangiectasia mutated and the risk of papillary thyroid carcinoma. Environ Mol Mutagen 2015; 56: 70-76.
6. Dombernowsky SL, Weischer M, Allin KH, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. Risk of cancer by ATM missense mutations in the general population. J Clin Oncol 2008; 26: 3057-3062.
7. Xu L , Morari EC, Wei Q, Sturgis EM, Ward LS. Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma. J Clin Endocrinol Metab 2012; 97: 1913-1921.
8. Gu Y , Yu Y, Ai L, Shi J, Liu X, Sun H, Liu Y. Association of the ATM gene polymorphisms with papillary thyroid cancer. Endocrine 2014; 45: 454-461.
9. Wójcicka A , Czetwertynska M, Swierniak M, et al. Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma. Genes Chromosomes Cancer 2014; 53: 516-523.
10. Damiola F1, Byrnes G, Moissonnier M, et al. Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation. Int J Cancer 2014; 134: 1659- 1668.
11. Nagasravani J , Chacham S , Narayan Reddy U, Narsing Rao J, Rao SP, Mahmood A. A rare case of ataxia telangiectasia in a 9-year-old female child. Pediatr Neurol 2014; 51: 583-584.
12. Chopra C, Davies G, Taylor M, Anderson M, Bainbridge S, Tighe P, McDermott EM. Immune deficiency in Ataxia-Telangiectasia: a longitudinal study of 44 patients. Clin Exp Immunol 2014; 176: 275-282.
13. Suarez F , Mahlaoui N , Canioni D , et al. Incidence, presentation, and prognosis of malignancies in ataxiatelangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol 2015; 33: 202-208.
14. Sandoval C , Swift M. Hodgkin disease in ataxiatelangiectasia patients with poor outcomes. Med Pediatr Oncol 2003; 40: 162-166.
15. Chung BM , Park SH, Kim SJ, Seo JS, Kim YS, Shim HJ, Lee JB. Papillary thyroid carcinoma in children and adolescents. Ultrasound Q 2014; 30: 193-196.
16. Noh BJ , Sung JY , Kim YW, Park YK. Recurrent thyroid papillary carcinoma in children under ten years old: report of two cases and literature review. Korean J Pathol, 2014; 48: 297-301.
17. Hecht F , Hecht BK. Cancer in ataxia-telangiectasia patients. Cancer Genet Cytogenet 1990; 46: 9-19.